Clinical Trials Directory

Trials / Unknown

UnknownNCT05882461

An E-health Letter Intervention for Caregivers

90Second Caregiver: A Randomized Control Trial of an E-health Letter for Caregivers

Status
Unknown
Phase
N/A
Study type
Interventional
Enrollment
330 (estimated)
Sponsor
IWK Health Centre · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the present study is to conduct a two-arm Randomized Control Trial (RCT) comparing individuals receiving the 90Second Caregiver health letter, with a usual care (routine care received by caregivers) control group. The goals of the present study are: * To evaluate the effectiveness of the 90Second Caregiver health letter in improving caregiver's self-efficacy (primary outcome), savouring, and quality of life (secondary outcomes). * To evaluate the effectiveness of the 90Second Caregiver health letter in reducing caregiver's psychological strain and caregiver burden (secondary outcomes). * To examine the impact of levels of engagement with the 90Second Caregiver health letter on primary and secondary outcomes. * To assess the usability of the 90Second Caregiver health letter, as it relates to the relevance of topic, user friendliness, and appropriateness of the readability levels. * To evaluate psychometric properties of self-constructed measures in 90Second newsletter.

Detailed description

The present study will examine the effectiveness of the 90Second Caregiver health letter in increasing self-efficacy in a sample of informal caregivers of ABI survivors in Nova Scotia. Participants in this study will be recruited from the Caring Forward Trials within Cohort Study (REB#1025253). The study is funded by the Nova Scotia Department of Health and Wellness.

Conditions

Interventions

TypeNameDescription
BEHAVIORAL90Second Caregiver health letterParticipant receives the weekly health letter via email

Timeline

Start date
2021-02-17
Primary completion
2024-03-01
Completion
2024-03-01
First posted
2023-05-31
Last updated
2023-05-31

Locations

1 site across 1 country: Canada

Source: ClinicalTrials.gov record NCT05882461. Inclusion in this directory is not an endorsement.